Atropine Sulfate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Atropine Sulfate Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Jan 1, 2012. Reported reason: Other
Shortage details
- Status
- Current
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-1630-10
- Dosage Form
- Injection
- Presentation
- Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-1630-10)
- Initial Posting
- Jan 1, 2012
Reason
Other